Ariad Written Description Ruling Could Significantly Impact Biotech Patents
Ariad Written Description Ruling Could Significantly Impact Biotech Patents
By:
The fate of many chemical and biotechnology patents will soon depend on the Federal Circuit's interpretation of the first paragraph of section 112 of the Patent Act.